Surgical treatment of advanced medication-related osteonecrosis of the jaws: Comparison of soft tissue closure techniques and evaluation of side effects
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 48 (9) , 896-901
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Resective Surgical Approach Shows a High Performance in the Management of Advanced Cases of Bisphosphonate-Related Osteonecrosis of the Jaws: A Retrospective Survey of 347 CasesJournal of Oral and Maxillofacial Surgery, 2012
- Bisphosphonate-related osteonecrosis of the jaws – Characteristics, risk factors, clinical features, localization and impact on oncological treatmentJournal of Cranio-Maxillofacial Surgery, 2012
- The use of pedicled buccal fat pad combined with sequestrectomy in bisphosphonate-related osteonecrosis of the maxillaMedicina Oral Patología Oral y Cirugia Bucal, 2012
- Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancerBreast Cancer Research and Treatment, 2011
- The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jawOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2011
- Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the JawJournal of Clinical Oncology, 2009
- Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a metanalysisBreast Cancer Research and Treatment, 2009
- The Role of Surgical Resection in the Management of Bisphosphonate-Related Osteonecrosis of the JawsJournal of Oral and Maxillofacial Surgery, 2009
- Treatment results of bisphosphonate‐related osteonecrosis of the jawsHead & Neck, 2008
- Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous BisphosphonatesJournal of Bone and Mineral Research, 2008